Exploring the role of novel agents in the treatment of renal cell carcinoma.

Maluf, Fernando Cotait

Exploring the role of novel agents in the treatment of renal cell carcinoma. [electronic resource] - Cancer treatment reviews Dec 2008 - 750-60 p. digital

Publication Type: Journal Article; Review

1532-1967

10.1016/j.ctrv.2008.07.002 doi


Aged
Aged, 80 and over
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--adverse effects
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Benzenesulfonates--adverse effects
Bevacizumab
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug Delivery Systems
Female
Humans
Indoles--adverse effects
Kidney Neoplasms--drug therapy
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Nephrectomy--methods
Niacinamide--analogs & derivatives
Phenylurea Compounds
Prognosis
Pyridines--adverse effects
Pyrroles--adverse effects
Sirolimus--adverse effects
Sorafenib
Sunitinib
Survival Analysis
Treatment Outcome